Adaptive Biotechnologies Corp Stock Price Prediction
| ADPT Stock | USD 2.60 0.02 0.78% |
Oversold Vs Overbought
36
Oversold | Overbought |
Adaptive Biotechnologies stock price prediction is an act of determining the future value of Adaptive Biotechnologies shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Adaptive Biotechnologies' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adaptive Biotechnologies and does not consider all of the tangible or intangible factors available from Adaptive Biotechnologies' fundamental data. We analyze noise-free headlines and recent hype associated with Adaptive Biotechnologies Corp, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Adaptive Biotechnologies' stock price prediction:EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (1.30) | EPS Estimate Next Year (1.04) | Wall Street Target Price 6.4 | EPS Estimate Current Quarter (0.33) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Adaptive Biotechnologies based on different types of headlines from major news networks to social media. The Adaptive stock price prediction module provides an analysis of price elasticity to changes in media outlook on Adaptive Biotechnologies over a specific investment horizon. Using Adaptive Biotechnologies hype-based prediction, you can estimate the value of Adaptive Biotechnologies Corp from the perspective of Adaptive Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Adaptive Biotechnologies using Adaptive Biotechnologies' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Adaptive using crowd psychology based on the activity and movement of Adaptive Biotechnologies' stock price.
Adaptive Biotechnologies Short Interest
A significant increase or decrease in Adaptive Biotechnologies' short interest from the previous month could be a good indicator of investor sentiment towards Adaptive. Short interest can provide insight into the potential direction of Adaptive Biotechnologies stock and how bullish or bearish investors feel about the market overall. An investor who is long Adaptive Biotechnologies may also wish to track short interest. As short interest increases, investors should be becoming more worried about Adaptive Biotechnologies and may potentially protect profits, hedge Adaptive Biotechnologies with its derivative instruments, or be ready for some potential downside.
200 Day MA 4.7852 | Short Percent 0.0885 | Short Ratio 5.28 | Shares Short Prior Month 9.1 M | 50 Day MA 3.2921 |
Adaptive Biotechnologies Hype to Price Pattern
Investor biases related to Adaptive Biotechnologies' public news can be used to forecast risks associated with an investment in Adaptive. The trend in average sentiment can be used to explain how an investor holding Adaptive can time the market purely based on public headlines and social activities around Adaptive Biotechnologies Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Adaptive Biotechnologies' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Adaptive Biotechnologies.
Adaptive Biotechnologies Implied Volatility | 120.69 |
Adaptive Biotechnologies' implied volatility exposes the market's sentiment of Adaptive Biotechnologies Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adaptive Biotechnologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adaptive Biotechnologies stock will not fluctuate a lot when Adaptive Biotechnologies' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Adaptive Biotechnologies. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Adaptive Biotechnologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Adaptive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adaptive Biotechnologies after-hype prediction price | USD 2.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adaptive |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adaptive Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adaptive Biotechnologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Adaptive Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adaptive Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adaptive Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Adaptive Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Adaptive Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adaptive Biotechnologies' historical news coverage. Adaptive Biotechnologies' after-hype downside and upside margins for the prediction period are 0.13 and 7.69, respectively. We have considered Adaptive Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adaptive Biotechnologies is unstable at this time. Analysis and calculation of next after-hype price of Adaptive Biotechnologies is based on 3 months time horizon.
Adaptive Biotechnologies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Adaptive Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adaptive Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adaptive Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.53 | 5.15 | 0.06 | 0.69 | 10 Events / Month | 4 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.60 | 2.54 | 2.31 |
|
Adaptive Biotechnologies Hype Timeline
Adaptive Biotechnologies is presently traded for 2.60. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of -0.69. Adaptive is projected to decline in value after the next headline, with the price expected to drop to 2.54. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.31%, whereas the daily expected return is presently at -0.53%. The volatility of related hype on Adaptive Biotechnologies is about 397.38%, with the expected price after the next announcement by competition of 1.91. About 96.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adaptive Biotechnologies recorded a loss per share of 1.56. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Adaptive Biotechnologies Basic Forecasting Models to cross-verify your projections.Adaptive Biotechnologies Related Hype Analysis
Having access to credible news sources related to Adaptive Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Adaptive Biotechnologies' future price movements. Getting to know how Adaptive Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adaptive Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LH | Laboratory of | 0.52 | 11 per month | 0.00 | (0.18) | 1.48 | (2.03) | 5.31 | |
| IDXX | IDEXX Laboratories | (5.93) | 11 per month | 0.00 | (0.11) | 2.37 | (2.31) | 11.55 | |
| RVTY | Revvity | (1.69) | 12 per month | 0.00 | (0.08) | 2.18 | (3.32) | 8.66 | |
| CDNA | Caredx Inc | (0.04) | 8 per month | 0.00 | (0.03) | 9.53 | (6.93) | 27.30 | |
| GH | Guardant Health | 0.66 | 12 per month | 0.00 | (0.11) | 5.84 | (7.29) | 22.73 |
Adaptive Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Adaptive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adaptive using various technical indicators. When you analyze Adaptive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adaptive Biotechnologies Predictive Indicators
The successful prediction of Adaptive Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adaptive Biotechnologies Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adaptive Biotechnologies based on analysis of Adaptive Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adaptive Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adaptive Biotechnologies's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 14.91 | 7.16 | 12.67 | 7.5 | Days Of Inventory On Hand | 142.61 | 91.1 | 53.93 | 51.23 |
Story Coverage note for Adaptive Biotechnologies
The number of cover stories for Adaptive Biotechnologies depends on current market conditions and Adaptive Biotechnologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adaptive Biotechnologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adaptive Biotechnologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Adaptive Biotechnologies Short Properties
Adaptive Biotechnologies' future price predictability will typically decrease when Adaptive Biotechnologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adaptive Biotechnologies Corp often depends not only on the future outlook of the potential Adaptive Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adaptive Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 144.4 M | |
| Cash And Short Term Investments | 346.4 M |
Check out Adaptive Biotechnologies Basic Forecasting Models to cross-verify your projections. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.56) | Revenue Per Share 1.179 | Quarterly Revenue Growth (0.17) | Return On Assets (0.17) | Return On Equity (0.58) |
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.